
Breakthru Medicine Secures $60M Funding for Cancer Therapies
Phoenix, February 10, 2026 Phoenix-based biotech startup Breakthru Medicine has successfully closed a $60 million Series A financing round, catalyzing the advancement of innovative cancer therapies.








